Navigation Links
Returning Life to Normal for Those with Painful Diabetic Neuropathy
Date:1/8/2014

WALTHAM, Mass., Jan. 8, 2014 /PRNewswire/ -- Living with diabetes can be tough any way one slices it. In addition to the challenges of managing one's diet and blood sugar levels, patients can experience shooting, stabbing or burning pains in their hands or feet unexpectedly and for no apparent reason.

This condition is called painful diabetic neuropathy (PDN), and many with the condition are forced to deal with it on a daily basis. Imagine waking up in the middle of the night because one's hands, feet or other extremities feel like they're on fire. Imagine not being able to hold a coffee cup or manipulate a pen. What must it be like to have to severely curtail one's physical activities? Such bleak scenarios are common among PDN patents. In addition to the pain, many with PDN also have damaged sensory nerves that can make them unaware of foot injuries as well as taking an enormous psychological toll on them and their loved ones.

Thanks to a Waltham, MA-based company named NeuroMetrix, Inc., it's possible for PDN patients to perform most physical activities while receiving treatment. NeuroMetrix has created the SENSUS™ Pain Management System, an innovative new device that can be worn right under clothing.

Lightweight, discreet and wrapping directly around the patient's calves, SENSUS's easy, one-button control makes it an ideal treatment for PDN patients of any age. It is non-addictive and non-narcotic, yet powerful enough to provide fast, long-lasting pain relief, even during sleep: SENSUS is the first transcutaneous electrical nerve stimulator cleared by the U.S. Food and Drug Administration to be used while sleeping. The device immediately shuts off if it becomes dislodged for any reason.

As Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix, explains, "One of the most ironic 'Catch 22s' of diabetes is how the need for exercise and other regular physical movement can be rendered virtually impossible when one is also dealing with PDN. We provide PDN patients with a device that can help them go about living their lives with relative normalcy."

For more, visit www.neurometrix.com, who paid for the writing and dissemination of this release.

Contact:  Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Growing Cost of Aging: Express Scripts Study Shows Medication Use for Normal Aging Conditions Overtakes Costs of Treating Most Chronic Diseases
2. Sequenom CMMs MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
3. Plaintiff in Prolift Vaginal Mesh Case Testifies She Can No Longer Work, Have Sex, or Function Normally, Rottenstein Law Group Reports
4. Dr. Diana Bianchi Presents Data Demonstrating Verinata Healths Proprietary Technology Detects Genetic Abnormalities In Twin Pregnancies
5. Rotech Receives Approval of First Day Motions; Approvals Ensure Operations Continue Normally
6. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
7. Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
8. Protein Targeted For Cancer Drug Development Is Essential For Normal Heart Function
9. New Survey: Hispanic Teen Drug Use Significantly Higher Than Other Ethnic Groups, Substance Abuse Becoming Normalized Behavior Among Latino Youth
10. Vivant Skin Care Introduces 8% Mandelic Acid 3-in-1 Serum for Those New to Advanced Skin Care
11. US Vitamin Injections Posts New Article to Help those Stalling on the HCG Diet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Urinary Incontinence Drugs Price ... in the global Urinary Incontinence market. The research answers the ... drugs marketed for Urinary Incontinence and their clinical attributes? How are ...
(Date:2/23/2017)... Research and Markets has announced the addition ... - 2016" report to their offering. ... The latest research Autism Spectrum Disorder ... and benchmarks in the global Autism Spectrum Disorder market. The ... are the key drugs marketed for Autism Spectrum Disorder and their ...
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG ... für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des ... ultraviolette Strahlung im Bereich zwischen 200 und 280 nm und ... von Bakterien, indem es ihre DNA zerstört. Das Produkt ... ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... , ... With ProGlass Prism users now have the ability to simulate prism ... position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor ... Prism users are given the tools and effects to generate a fractal prismatic ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
Breaking Medicine News(10 mins):